Header Logo

Connection

Mary Fidler to Prostaglandins

Back to Details
This is a "connection" page, showing publications Mary Fidler has written about Prostaglandins.
Mary Fidler
Connection Strength
0.120
Prostaglandins
  1. Randomized, double-blind, placebo-controlled, multicenter phase II study of the efficacy and safety of apricoxib in combination with either docetaxel or pemetrexed in patients with biomarker-selected non-small-cell lung cancer. J Clin Oncol. 2015 Jan 10; 33(2):189-94.
    View in: PubMed
    Score: 0.120
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.